Awakn Life Sciences Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AWKNF research report →
About the company
Awakn Life Sciences Corp., a biotechnology firm, focuses on pioneering, advancing, implementing, and distributing psychedelic therapies to combat addiction and various other mental health conditions. Operating across the United Kingdom and Europe, the company maintains its corporate headquarters in Toronto, Canada.
- CEO
- Anthony Tennyson
- IPO
- 2021
- Employees
- 6
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $2.71M
- P/E
- -0.28
- P/S
- 2.58
- P/B
- 2.97
- EV/EBITDA
- -1.13
- Div Yield
- 0.00%
- Gross Margin
- -103.97%
- Op Margin
- -614.85%
- Net Margin
- -611.40%
- ROE
- -429.34%
- ROIC
- -331.42%
- Revenue
- $87.37K · -94.16%
- Net Income
- $-5,102,704 · 44.19%
- EPS
- $-0.13 · 63.89%
- Op Income
- $-3,926,493
- FCF YoY
- 68.07%
- 52W High
- $0.13
- 52W Low
- $0.05
- 50D MA
- $0.07
- 200D MA
- $0.07
- Beta
- 2.60
- Avg Volume
- 8.84K
Get TickerSpark's AI analysis on AWKNF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our AWKNF coverage
Recent articles, reports, and earnings notes.
No research on AWKNF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AWKNF report →Similar companies
Peers in the same neighborhood.